Europe advanced medical stopcock market is expected to reach US$ 321.6 Mn in 2027 from US$ 237.2 Mn in 2018. The market is projected to grow with a CAGR of 3.6% from 2019-2027.
Increasing geriatric population, rising prevalence lung cancer, consumption of the alcohol and tobacco, illegal drugs are fostering the growth of the intravenous and infusion therapies which in return resulting into the higher demand for medical stopcocks. However, the market is likely to get impacted by the risk factor such as safety concerns for using stopcocks during the forecast period.
Alzheimer disease and dementia, asthma, cancer, COPD, cystic fibrosis, diabetes, heart diseases are few of the leading chronic diseases that may cause death in individuals. The practice such as use of tobacco, alcohol consumption, poor nutrition and lack of physical activity among others are the leading factors for the chronic diseases. Therefore, the cases of chronic diseases is increasing these days. For instance, In Germany the risk of the chronic obstructive pulmonary disease (COPD) has a high prevalence rate and is expected to increase in the coming days. The leading cause of death in Germany is COPD; thus it is listed in the high disease burden. As per a report published in 2018, stated that approximately 12% of the older adults in Germany suffer from COPD. In 2016, nearly 7 million were registered with COPD in the country, and it is estimated that the number will increase to 8 million by 2030. According to the World Health Organization (WHO), it is estimated that COPD is expected to be the third most often cause of death by 2030.
Major Key Players of the Europe Advanced Medical Stopcock Market are:
B. BRAUN MELSUNGEN , SMITHS MEDICAL , NIPRO , ELCAM MEDICAL , MERIT MEDICAL SYSTEMS , CODAN USA , NORDSON CORPORATION , COOK , JCM MED , UTAH MEDICAL PRODUCTS INC
B. BRAUN MELSUNGEN , SMITHS MEDICAL , NIPRO , ELCAM MEDICAL , MERIT MEDICAL SYSTEMS , CODAN USA , NORDSON CORPORATION , COOK , JCM MED , UTAH MEDICAL PRODUCTS INC
In 2018, Europe advanced medical stopcock market held a market share of 28.20% of the global advanced medical stopcock market. The low-pressure stopcocks segment expected to dominate its market share and was valued at US$ 129.3 Mn in 2018 and is anticipated to reach US$ 180.0 Mn by 2027. . On the other hand, low-pressure stopcocks segment is also anticipated to witness the fastest growth rate of 4.0% during the forecast period, 2019 to 2027.
Research objectives:-– To study and analyze the global Europe Advanced Medical Stopcock consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the Europe Advanced Medical Stopcock market by identifying its various sub-segments.
– Focuses on the key global Europe Advanced Medical Stopcock manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Europe Advanced Medical Stopcock with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
– To understand the structure of the Europe Advanced Medical Stopcock market by identifying its various sub-segments.
– Focuses on the key global Europe Advanced Medical Stopcock manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the Europe Advanced Medical Stopcock with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Comments
Post a Comment